Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Pieter Van Vlierberghe

Faculty of Medicine and Health Sciences > Department of Biomolecular Medicine

Work address: C. Heymanslaan 10, ingang 38 (MRB2)
9000 Gent
Email: Pieter.VanVlierberghe@UGent.be
ORCID iD: 0000-0001-9063-7205

Show Sort by

Add to list
Zeb2 drives invasive and microbiota-dependent colon carcinoma

Karolina Slowicka (UGent) , Ioanna Petta (UGent) , Gillian Blancke (UGent) , Esther Hoste (UGent) , Emilie Dumas (UGent) , Mozes Sze (UGent) , Hanna-Kaisa Vikkula (UGent) , Enrico Radaelli, Jody J. Haigh, Sven Jonckheere (UGent) , et al.

(2020) NATURE CANCER. 1. p.620-634
Add to list
- Miscellaneous
Publisher correction : Zeb2 drives invasive and microbiota-dependent colon carcinoma

Karolina Slowicka (UGent) , Ioanna Petta (UGent) , Gillian Blancke (UGent) , Esther Hoste (UGent) , Emilie Dumas (UGent) , Mozes Sze (UGent) , Hanna-Kaisa Vikkula (UGent) , Enrico Radaelli, Jody J. Haigh, Sven Jonckheere (UGent) , et al.

(2020) NATURE CANCER. 1. p.750-750
Add to list
The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

Niels Vandamme (UGent) , Geertrui Denecker, Kenneth Bruneel (UGent) , Gillian Blancke (UGent) , Ozden Akay (UGent) , Joachim Taminau (UGent) , Jordy De Coninck (UGent) , Eva De Smedt (UGent) , Nicolas Skrypek (UGent) , Wouter Van Loocke (UGent) , et al.

(2020) CANCER RESEARCH. 80(14). p.2983-2995
Add to list
Distinct and temporary-restricted epigenetic mechanisms regulate human αβ and γδ T cell development

Juliette Roels (UGent) , Anna Kuchmiy (UGent) , Matthias De Decker (UGent) , Steven Strubbe (UGent) , Marieke Lavaert (UGent) , Kai Ling Liang (UGent) , Georges Leclercq (UGent) , Bart Vandekerckhove (UGent) , Filip Van Nieuwerburgh (UGent) , Pieter Van Vlierberghe (UGent) , et al.

(2020) NATURE IMMUNOLOGY.
Add to list
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis

E. G. Garcia, A. Veloso, M. L. Oliveira, J. R. Allen, S. Loontiens, D. Brunson, D. Do, C. Yan, R. Morris, S. Iyer, et al.

(2020) LEUKEMIA.
Add to list
A novel TLX1-driven T-ALL zebrafish model : comparative genomic analysis with other leukemia models

Siebe Loontiens (UGent) , Suzanne Vanhauwaert (UGent) , Lisa Depestel (UGent) , Givani Dewyn (UGent) , Wouter Van Loocke (UGent) , Finola E. Moore, Elaine G. Garcia, Lance Batchelor, Chiara Borga, Barbara Squiban, et al.

(2020) LEUKEMIA.
Add to list
- Conference Paper
- C3
- open access
Teaching an old dog new tricks : activity-on-target interferon to treat T-cell acute lymphoblastic leukemia

Steven Goossens (UGent) , Anje Cauwels (UGent) , Tim Pieters (UGent) , Willem Daneels (UGent) , Pieter Van Vlierberghe (UGent) and Jan Tavernier (UGent)

(2020) EHA25 Virtual - The European Hematology Association, Abstracts.
Add to list
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia

Andreas Kloetgen, Palaniraja Thandapani, Panagiotis Ntziachristos, Yohana Ghebrechristos, Sofia Nomikou, Charalampos Lazaris, Xufeng Chen, Hai Hu, Sofia Bakogianni, Jingjing Wang, et al.

(2020) NATURE GENETICS. 52(4). p.388-400+
Add to list
- Miscellaneous
Chemotherapy at the wheel of ALL relapse

Julie Morscio (UGent) and Pieter Van Vlierberghe (UGent)

(2020) BLOOD. 135(1). p.3-5
Add to list
HES1 and HES4 have non-redundant roles downstream of Notch during early human T cell development.

Matthias De Decker (UGent) , Marieke Lavaert (UGent) , Juliette Roels (UGent) , Laurentijn Tilleman (UGent) , Bart Vandekerckhove (UGent) , Georges Leclercq (UGent) , Filip Van Nieuwerburgh (UGent) , Pieter Van Vlierberghe (UGent) and Tom Taghon (UGent)

(2020) HAEMATOLOGICA.

1
2
3
4
…
17
18

Next →